Flex Pharma Announces Reduction of Muscle Cramping in Athletes
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
Flex Pharma (FLKS) Announces Statistically Significant Data from Muscle Cramp Study
July 7, 2015 9:24 AM EDTFlex Pharma (NASDAQ: FLKS) announced its proprietary treatment prevented muscle cramps in an initial study of athletes participating in high intensity sports.
We believe this is the first time any consumer beverage has shown a statistically significant reduction of naturally occurring muscle cramps in... More
